PM Images Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting individual fund news and events – as well as the top-down – providing an overview of the broader market. We also try to provide some historical context as well…
ElementalImaging/E+ via Getty Images Ferroglobe PLC (NASDAQ:GSM) reported Q1 2024 results this week. EBITDA came in at $25.8 million, down from $60.3 million in Q4 and $44.8 million in Q1 last year. The profitability drop is not that surprising. Q1 is usually the seasonally slowest volume quarter, and pricing was weak across the board. Silicon…
D-Keine Deals and Financings Hangzhou Sciwind Biosciences out-licensed South Korean rights for ecnoglutide injection (XW003), a novel long-acting GLP-1 analog aimed at type 2 diabetes, obesity and MASH, to HK inno.N Corporation (KOSDAQ: 195940). HK inno.N is a South Korean commercial stage pharmaceutical company. Sciwind will receive an unspecified upfront payment and additional milestones of…
J Studios Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both the bottom-up – highlighting individual news and events – as well as the top-down – providing an overview of the broader market. We also try to add some historical…
Brett_Hondow/iStock Editorial via Getty Images Introduction In “Big Tech’s Big Breakdown, The Technical Setup Ahead Of Earnings,” I wrote the following about Amazon.com, Inc. (NASDAQ:AMZN): Along with Meta and Google, Amazon has been one of our largest holdings at TQI since its inception in late 2022. After being undervalued throughout 2022-23, Amazon’s stock has finally…
bankerwin Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity from both the bottom-up, highlighting individual news and events, as well as top-down, providing an overview of the broader market. We also try to add some historical context as well as relevant themes that…
Jordan Siemens/DigitalVision via Getty Images Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting individual fund news and events – as well as the top-down – providing an overview of the broader market. We also try to provide some historical…
bibikoff/iStock via Getty Images For many investors, navigating the complexities of the financial markets can feel like a jungle. Trapped between the allure of high returns and the fear of significant losses, indecision makes it easy to feel paralyzed. This past year, I embarked on an experiment to inject fun and clarity into the investment…
Pgiam/iStock via Getty Images Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity from both the bottom-up, highlighting individual news and events, as well as top-down, providing an overview of the broader market. We also try to add some historical context as well as…
Sakorn Sukkasemsakorn 2023 Stock Market Review The market in 2023 was a tough one to figure out as the “Magnificent 7” of big tech marched higher while the rest of the market spun its wheels waiting for the recession that still hasn’t come. The debt ceiling drama turned into a nothing burger and rising interest…
Pgiam/iStock via Getty Images Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity from both the bottom-up, highlighting individual news and events, as well as top-down, providing an overview of the broader market. We also try to add some historical context as well as…
Hispanolistic/E+ via Getty Images The March jobs report came in at 303,000, which was significantly more than expected. Initial expectations had been for 200,000 jobs and FOMC hawks have been talking about no cuts this year, yet markets rallied. While the market initially sold off, it recovered shortly after the report. The headline unemployment number…
deepblue4you Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity from both the bottom-up, highlighting individual news and events, as well as top-down, providing an overview of the broader market. We also try to add some historical context as well as relevant themes that…
simarik Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund [CEF] market activity from both the bottom-up – highlighting individual fund news and events – as well as the top-down – providing an overview of the broader market. We also try to provide some historical context as well as…
champpixs It has been nearly four years since I wrote about Westport Fuel Systems Inc. (NASDAQ:WPRT) on Seeking Alpha. On June 9, 2020. WPRT was trading below the $1.50 per share level in June 2020 on a pre-split basis when I wrote: In a world that looks for a cleaner environment, the addressable market for…
Liudmila Chernetska/iStock via Getty Images Investment Thesis PPG Industries, Inc. (NYSE:PPG) shares have gained about 11% over the last year. Although this stock has an attractive dividend policy and its growth metrics are very appealing, my midterm outlook of this stock is skeptical following its strategic review of North American architectural coatings. From a technical…
A-Ko-N/iStock via Getty Images Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both the bottom-up – highlighting individual news and events – as well as the top-down – providing an overview of the broader market. We also try to add…
sshepard Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both the bottom-up – highlighting individual news and events – as well as the top-down – providing an overview of the broader market. We also try to add some historical context…
stephanie phillips/E+ via Getty Images Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (CEF) market activity from both the bottom-up – highlighting individual fund news and events – as well as the top-down – providing an overview of the broader market. We also try to provide some historical…
Lemon_tm/iStock via Getty Images Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity from both the bottom-up, highlighting individual news and events, as well as the top-down, providing an overview of the broader market. We also try to add some historical context as well…
Andriy Onufriyenko/Moment via Getty Images Investment Overview Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), the Carlsbad, California-based, commercial stage pharmaceutical company, announced its Q4 and full-year 2023 earnings on Wednesday after the market close. Ionis stock presently trades at around a value of $45.5 per share, and the market appears to have been largely unmoved by this latest…
Over the past decade, Coinbase has reached millions of cryptocurrency traders and expanded to become the largest crypto exchange in the US. Despite its solid reputation, Coinbase did not avert scrutiny and skepticism. It has intensified in the past two years, driven by the sharp upsurge and plunge in crypto prices in a short period….
stanley45/iStock via Getty Images Age-related macular degeneration (AMD) is the most common cause of central vision loss and blindness in adults. Wet AMD comprises 25% of all cases of AMD and is characterized by new blood vessel formation in and under the retina. 75% of AMD is due to dry AMD (no new blood vessel…
Wirestock/iStock via Getty Images Well managed businesses are rare, especially in the real estate space. There are hundreds of public REITs and few stand out in their areas of expertise. Some of the largest names such as Realty Income (O) tout long, established histories that investors point to for validation. Some look to copy proven…
Darren415 Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting individual fund news and events – as well as the top-down – providing an overview of the broader market. We also try to provide some historical context as well as…
marrio31 Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both the bottom-up – highlighting individual news and events – as well as the top-down – providing an overview of the broader market. We also try to add some historical context…
ALIOUI Mohammed Elamine/iStock via Getty Images Deals and Financings ArriVent BioPharma (AVBP), a Philadelphia in-licensing company, priced its upsized NASDAQ IPO at $18 per share, raising $175 million (see story). The company’s stated goal is to find promising novel assets from China and other countries, which it brings to the US market. ArriVent’s lead product…
BrianAJackson/iStock via Getty Images 2023 was another good year for Lyrical. Our CS composite returned 27.2%, outperforming the S&P 500 (SP500, SPX) by 90 bps. It was a particularly difficult year to outperform given the outsized performance contribution of the Magnificent Seven mega-cap growth stocks. We, as value investors, do not own any of the…
JHVEPhoto Brief Review Of ServiceNow’s Q4 2023 Earnings Report Heading into its Q4 2023 report, ServiceNow, Inc. (NYSE:NOW) was projected to deliver revenues and normalized EPS of $2.40B and $2.78, respectively. SeekingAlpha With ServiceNow beating consensus street estimates on both top and bottom lines [revenue: $2.44B (up +25.78% y/y), normalized EPS: $3.11], the stock is…
Ton Photograph 2023 is over, and with it my fourth year of publicly tracking my portfolio and its performance. It was anyone’s guess what the year would look like as the stock market came out of a significant downturn. Interest rates were still rising, inflation was still at the top of most people’s minds, and…
Darren415 Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting individual fund news and events – as well as the top-down – providing an overview of the broader market. We also try to provide some historical context as well as…
monsitj CEF Insights Quarterly Review January 2024 Interview – Tom Roseen CEFA: Welcome to CEF Insights, your source for closed-end fund information and education, brought to you by the Closed-End Fund Association. Today, we are joined again by Tom Roseen, Head of Research Services with LSEG Lipper, and author of the Fund Market Insight Report,…
pcess609 Over the last fourteen years of dividend growth investing, my portfolio, goals, and rules have evolved. Along with the changes, I have made plenty of mistakes along the way. However, through it all, the income has consistently grown at 10% annually. Investing in high-quality dividend growth companies has proven to be a forgiving strategy….
John Kevin/iStock via Getty Images In this 2023 year-end sector review, part 2, we look at what kind of year it was for healthcare, industrial, technology, materials, REITs, and utility sectors. How is 2024 shaping up for them? Missed part 1 of our 2023 year-end sector review? No worries, read it here. Healthcare If you…
This article was written by Follow Dividends (DGI and DRIP) and Growth at reasonable price (GARP) for Long-term. Serious money.Fun trading for short-term. Play money.Ideas and thoughts presented in the articles are not professional recommendations. Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans…
FinkAvenue Intel Corporation (NASDAQ:INTC) was announced as our top investment recommendation for 2023 at the start of the year. Since that article was written, the company has had a total return of more than 70%, versus the S&P 500 (SP500), which returned just over 20%. As we’ll see throughout this article, despite tripling the market,…
mphillips007 Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both the bottom-up – highlighting individual news and events – as well as the top-down – providing an overview of the broader market. We also try to add some historical context…
Parradee Kietsirikul/iStock via Getty Images Usual end of year review here. It hasn’t gone well, overall, +0.8 (excluding Russian frozen stocks) or +5.4% including Russian frozen stocks. If Russia goes back to normal, will be up far more as there are a lot of dividends waiting to be collected, not included in the below. Linking…
William_Potter Real estate securities rebounded sharply in December, leading the broad-based gains for the major asset classes in the final month of 2023, based on a set of ETFs. Commodities, by contrast, were the downside outlier for December and for the calendar year that just ended. Vanguard US Real Estate Index Fund (VNQ) surged 9.4%…
hh5800/iStock via Getty Images Deals and Financings Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma (OTCPK:ALPMF, TSE: 4503) to develop a novel bispecific macrophage engager, ES019, along with an unspecified program (see story). Initially, Elpiscience will receive up to $37 million, including an upfront payment and license option fees. Astellas…
Wirestock Manole Capital Management -4th Quarter Investor Newsletter (December 2023) Introduction: You don’t drive a car by just looking in the rearview mirror. You need various inputs (weather conditions, traffic, fuel, etc.), but also must anticipate the road in front of you. The Fed is analyzing current data and all the leading economic indicators, but…
PeopleImages Deals and Financings GSK acquired ex-Greater China rights to a second ADC from Jiangsu’s Hansoh Pharma in a $1.7 billion agreement (see story). GSK’s latest acquisition, HS-20093, is a B7-H3 targeted antibody-drug conjugate (ADC) with a topoisomerase inhibitor (TOPOi) payload that is in China Phase I/II trials for solid tumor cancers. Hansoh will receive…
Darren415 Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity from both the bottom-up, highlighting individual news and events, as well as the top-down, providing an overview of the broader market. We also try to add some historical context as well as relevant themes…
Torsten Asmus Welcome to another installment of our CEF Market Weekly Review, where we discuss closed-end fund (“CEF”) market activity from both the bottom-up – highlighting individual fund news and events – as well as the top-down – providing an overview of the broader market. We also try to provide some historical context as well…
Darren415 Welcome to another installment of our Preferreds Market Weekly Review, where we discuss preferred stock and baby bond market activity from both the bottom-up, highlighting individual news and events, as well as the top-down, providing an overview of the broader market. We also try to add some historical context as well as relevant themes…
ClaudioVentrella/iStock via Getty Images Deals and Financings SystImmune, the Seattle arm of Chengdu’s Biokin Pharma, out-licensed global rights (ex-China) for a bispecific ADC to Bristol Myers Squibb (BMY) in a $8.4 billion agreement (see story). SystImmune will receive $800 million upfront and up to $500 million in contingent near-term payments. The candidate, BL-B01D1, is a…
Yossakorn Kaewwannarat Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both the bottom-up – highlighting individual news and events – as well as the top-down – providing an overview of the broader market. We also try to add some historical…
S&P Global Ratings senior analyst Lapo Guadagnuolo believes that the growth of stablecoins does not mean that they are immune to risk factors. The S&P Global Ratings introduced a stability assessment for stablecoins on Tuesday. According to S&P Global, the idea is to determine how truly “stable” the coins are in maintaining their pegs to…
Darren415 Welcome to another installment of our BDC Market Weekly Review, where we discuss market activity in the Business Development Company (“BDC”) sector from both the bottom-up – highlighting individual news and events – as well as the top-down – providing an overview of the broader market. We also try to add some historical context…
“It’s hard,” Harry Turtledove declared in 2001, in his Introduction to The Best Alternate History Stories of the 20th Century, “to write about the effects of technology before there’s much in the way of technology to write about.” Two decades on, futurism remains as hard an endeavor as ever, and it’s precisely this problem of…